Cetuximab/inrinotecan/high dose 5 FU/LV (HD-5-FU/LV) in the first-line therapy of metastatic colorectal cancer (CRC). - Folprecht,G.; Lutz,M.; Schöffski,P. (Proc Gastrointest Cnac Symp (ASCO/AGA/ASTRO/SSO), 2004)